Regulatory approval of Pfizer/BioNTech vaccine for COVID-19, MHRA (updated 3rd December 2021)
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine. 3 December 2021The Pfizer/BioNTech vaccine (Comirnaty) Conditional Marketing Authorisation has been renewed: changes to the SmPC – section 9 and section 10. 15 November 2021Updated sections of the Summary of Product Characteristics and Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech (Conditional Marketing Authorisation documents) to include information about receiving a 3rd/booster dose. Also to in clude two new reagents, Sodium Hydroxide and Hydrochloric Acid, which are used in small quantities during the...
Source: Current Awareness Service for Health (CASH) - December 3, 2021 Category: Consumer Health News Source Type: news

Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping
Princeton, NJ, Sandoz Inc. ( “Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion of lot SAB06761A experienced a temperature excursion during shipment. Enoxaparin Sodium for Injectio (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 2, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How Your Post-Thanksgiving Diet Could Help Save the Planet
As you tuck into your Thanksgiving dinner, the kick-off event (at least for Americans) of the holiday season, spare a thought for the planet’s carbon waistline. Food production is a major source of greenhouse gas emissions, accounting for more than a third of emissions worldwide — and a new study has given fresh insight into how small changes in the diet can have a big impact on food-related emissions. And even if it doesn’t inspire you to forgo the turkey and trimmings, it serves as a good reminder that a post-holiday pause on overindulgence might be just the kind of thanks Mother Earth might appreciate ...
Source: TIME: Health - November 24, 2021 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized climate change Climate Is Everything embargoed study healthscienceclimate Londontime overnight Source Type: news

A Critical Review of the Efficacy and Safety of Inclisiran A Critical Review of the Efficacy and Safety of Inclisiran
Review current evidence for the use of inclisiran sodium, a novel siRNA, for reducing LDL-C in patients with ASCVD at very high cardiovascular risk.American Journal of Cardiovascular Drugs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 24, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

A web-based control system for traditional street lighting that uses high-pressure sodium lamps - Thungtong A, Chaichan C, Suwannarat K.
Street lighting is a critical component of any city's infrastructure. On the other hand, the street lighting system consumes a significant amount of electricity. As a result, many technologies and studies are being developed to reduce the energy cost of st... (Source: SafetyLit)
Source: SafetyLit - November 24, 2021 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Lower Urinary Sodium, Higher Potassium Tied to Lower CV Risk Lower Urinary Sodium, Higher Potassium Tied to Lower CV Risk
A new observational study using direct urinary measurement, along with previous randomized data, provides support for public health advice to reduce sodium and increase potassium intake prevent CVD.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - November 17, 2021 Category: Primary Care Tags: Cardiology News Source Type: news

Qualitative assessment of caustic soda injury in Liberia - Zawolo J, Cohn KA, Kawah-Baysah M, Weah-Chenoway S, Gbozee L, Vinograd AM.
This study explored lye (caustic soda, sodium hydroxide) use in Liberia, knowledge about its risks and injury prevention programmes. DESIGN: A qualitative semistructured interview study. SETTING: Focus groups occurred in six Liberian co... (Source: SafetyLit)
Source: SafetyLit - November 15, 2021 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Comparison of the bleaching efficacy of different agents used for internal bleaching – a systematic review and meta-analysis
ConclusionsCarbamide peroxide, hydrogen peroxide, and sodium perborate have a significant bleaching effect on discolored, root-canal-treated teeth. For a valid assessment of shade stability and comparison of bleaching agents resp. their concentrations, further studies with long term recalls are necessary. (Source: Dental Technology Blog)
Source: Dental Technology Blog - November 11, 2021 Category: Dentistry Source Type: news

Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline du...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Rational basis for light emitting diode street lighting retrofit luminaire selection - Brons JA, Bullough JD, Frering DC.
Many municipalities are beginning to undertake efforts to retrofit their existing high pressure sodium (HPS) street lighting with LED (light emitting diode) luminaires. Unlike HPS lighting systems, which are available in a limited range of standard wattage... (Source: SafetyLit)
Source: SafetyLit - November 3, 2021 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Glenmark launches unique fixed dose combination drug for diabetes
The Mumbai based drug firm said it has introduced fixed dose combination (FDC) of its novel, patent protected Sodium Glucose Co-Transporter Inhibitor (SGLT2i) - Remogliflozin Etabonate and another widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) - Vildagliptin, with Metformin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 26, 2021 Category: Pharmaceuticals Source Type: news

The Big Number: Americans consume about 3,400 mg of salt per day, FDA says
Federal guidelines recommend eating no more than 2,300 mg per day for people 14 and older. Too much sodium can cause health problems, such as strokes and heart ailments. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 25, 2021 Category: Consumer Health News Authors: Linda Searing Source Type: news

Temporal Trends in Dietary Sodium Intake Among Adults Aged ≥19 Years - United States, 2003-2016
This report describes sodium intake among adults in the U.S. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - October 21, 2021 Category: American Health Tags: Adult Health Chronic Disease Chronic Disease Prevention Healthy Living Hypertension MMWR Morbidity & Mortality Weekly Report Sodium Salt Consumption Source Type: news

Charcoal-based dentifrices and powders: analyses of product labels, Instagram engagement, and altmetrics
In conclusion, charcoal-based products are using marketing strategies on Instagram but their current engagement with the public is not high. Consumers are being exposed to charcoal products whose potential risks to health are still unknown. (Source: Dental Technology Blog)
Source: Dental Technology Blog - October 15, 2021 Category: Dentistry Source Type: news

Actonel with Calcium (Risedronate Sodium with Calcium Carbonate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 14, 2021 Category: Drugs & Pharmacology Source Type: news

New FDA Guidance Aims to Cut Sodium in Processed Foods New FDA Guidance Aims to Cut Sodium in Processed Foods
New targets for industry seek to decrease average sodium intake from approximately 3400 mg/day to 3000 mg/day, about a 12% reduction, over the next 2.5 years, the FDA said.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 13, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

FDA Issues New Guidance To Reduce Salt In Food
The goal is to decrease average sodium intake for the average American by at least 12% over the next 2.5 years. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 13, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Food & Drink /food-drink pharma Source Type: news

FDA Calls For 12% Less Salt In Food From Restaurants, Manufacturers
Currently, the average American consumes about 3,400 milligrams of sodium a day, which is close to 50% higher than the recommended daily limit. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 13, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Food & Drink /food-drink pharma Source Type: news

FDA spells out lower sodium goals for food industry
Food companies are coming under renewed pressure to use less salt (Source: ABC News: Health)
Source: ABC News: Health - October 13, 2021 Category: Consumer Health News Tags: Health Source Type: news

How Cutting Out a Little Salt Can Have Benefits for Health and Blood Pressure
For many, reducing sodium in the diet even modestly can have an outsize impact on lowering blood pressure. (Source: NYT Health)
Source: NYT Health - October 11, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Salt Diet and Nutrition Cooking and Cookbooks Blood Pressure Weight Heart Food Source Type: news

Thyro-Tabs (Levothyroxine Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 6, 2021 Category: Drugs & Pharmacology Source Type: news

Opticrom (Cromolyn Sodium Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 6, 2021 Category: Drugs & Pharmacology Source Type: news

Sodium Sulfacetamide and Sulfur Lotion (Sulfacetamide and Sulfur Lotion) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 5, 2021 Category: Drugs & Pharmacology Source Type: news

Drug makers Glenmark, Aurobindo recall products in US
Glenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartrate Inhalation Solution. Aurobindo Pharma USA Inc, a unit of Aurobindo Pharma, is recalling 2,820 bottles of Metoprolol tartrate tablets". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 3, 2021 Category: Pharmaceuticals Source Type: news

Intal Inhaler (Cromolyn Sodium Inhalation Aerosol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 29, 2021 Category: Drugs & Pharmacology Source Type: news

New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

C-Section Anesthesia Adequacy With Two Sodium Thiopental Doses C-Section Anesthesia Adequacy With Two Sodium Thiopental Doses
This study aimed to determine the optimal sodium thiopental dose for Caesarean section which balances depth of anesthesia with the safety of the neonate. Should we still be using STP for c-sections?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2021 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

IntegraDose Compounding Services, LLC Issues Voluntary Nationwide Recall of Cefazolin Injection Products Due to a Lack of Sterility Assurance
Minneapolis, Minnesota, IntegraDose Compounding Services is voluntarily recalling nine lots, listed in the table below, of cefazolin 2 gram in 20 mL syringe for injection and two lots of cefazolin 3 gram in 100 mL 0.9% sodium chloride bag for injection due to a lack of sterility assurance resulting (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 21, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

New Data on RYBREVANT ® (amivantamab-vmjw) in Combination with Lazertinib Show Early Activity in Patients with Non-Small Cell Lung Cancer Whose Disease Has Progressed After Both Osimertinib and Platinum-Based Chemotherapy
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced preliminary results from the Phase 1b CHRYSALIS-2 (NCT04077463) study evaluating RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in the treatment of patients with non-small cell lung cancer (NSCLC) characterized by epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib and platinum chemotherapy.[i] While previously reported results have demonstrated durable responses with RYBREVANT® in combination with...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

RYBREVANT ® (amivantamab-vmjw) Provides Higher Activity and Longer Duration of Response When Used in Combination with Lazertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer Who Have Failed Osimertinib
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new analysis from the CHRYSALIS (NCT02609776) study evaluating RYBREVANT® (amivantamab-vmjw) monotherapy and a combination regimen with lazertinib in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who progressed after osimertinib.[1] The analysis showed higher activity and longer duration of response (DOR) in patients treated with the combination therapy, demonstrating the potential benefit of targeting the extracellular (outer) and catal...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral present...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

High Sodium Intake in Patients With POTS High Sodium Intake in Patients With POTS
Might increased dietary sodium intake reduce the symptoms of postural orthostatic tachycardia syndrome?Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 17, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Nonopioid Med Promising for Neuropathic Pain Nonopioid Med Promising for Neuropathic Pain
Top-line phase 2 data suggest vixotrigine, Biogen's investigational oral sodium channel blocker, eases pain caused by diabetes-associated small fiber neuropathy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 17, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Higher Sodium Intake May Be Tied to Worse Migraine Outcomes
THURSDAY, Sept. 9, 2021 -- A higher 24-hour urine sodium level is positively associated with worse migraine headache outcomes, according to a study published online Aug. 11 in the British Journal of Nutrition. Arman Arab, from the Isfahan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 9, 2021 Category: Pharmaceuticals Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What are Some of the Complications of Short Bowel Syndrome?
Discussion Necrotizing enterocolitis (NEC) is one of the most common gastrointestinal emergencies in neonates. Mortality rates are from 0-45% depending on infant weight and gestation with more premature and smaller infants having greater mortality. NEC usually occurs in premature infants but it also occurs in term infants. The etiology is unknown but is probably multifactorial with ischemia and/or reperfusion playing some role. There are ‘outbreaks’ of NEC but no causative organism has been identified. Regardless of the originating cause, inflammation of the intestine and release of inflammatory mediators cause...
Source: PediatricEducation.org - August 30, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Salt Substitute Reduces Stroke, CV Events, and Death Salt Substitute Reduces Stroke, CV Events, and Death
Switching from regular salt to a low-sodium salt substitute has major public health benefits, including a reduction in stroke, cardiovascular events, and death, the new landmark SSaSS shows.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 29, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

High blood pressure: The surprising food type rich in potassium to lower your readings
HIGH blood pressure, or hypertension as its often referred to, is a serious condition affecting millions worldwide. Diet is key when it comes to healthy readings with sodium or salt being the biggest precursor to increasing hypertension risk. A certain food type, however, has been shown to counteract sodium in the body which in turn lowers your readings. (Source: Daily Express - Health)
Source: Daily Express - Health - August 28, 2021 Category: Consumer Health News Source Type: news

Cultural Perspectives on Sodium Intake Reduction Among Nigerians in the US: An Application of the PEN-3 Model
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - August 26, 2021 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Salt & Low Sodium Diet Quiz
Title: Salt& Low Sodium Diet QuizCategory: MedicineNet QuizCreated: 8/2/2011 2:24:00 PMLast Editorial Review: 8/26/2021 5:49:08 PM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - August 26, 2021 Category: Cardiology Source Type: news

' High Normal' Sodium, Poor Hydration Linked to Heart Failure'High Normal' Sodium, Poor Hydration Linked to Heart Failure
A high normal sodium level in midlife may predict future heart failure. Patients should monitor hydration and clinicians should not assume a sodium level of 142 mmol/L is appropriate, researchers say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 25, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

LED streetlights decimating moth numbers in England
‘Eco-friendly’ lights found to be worse than sodium ones – but both contribute to insect decline, says study“Eco-friendly” LED streetlights produce even worse light pollution for insects than the traditional sodium bulbs they are replacing, a study has found.The abundance of moth caterpillars in hedgerows by rural roads in England was 52% lower under LED lights and 41% lower under sodium lights when compared with nearby unlit areas.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 25, 2021 Category: Science Authors: Damian Carrington Environment editor Tags: Insects Wildlife Conservation Environment England UK news Science Source Type: news

Tolectin (Tolmetin Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 25, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) e...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cadila inks pact with Italian firm to launch generic product in US
The partners plan to launch the product which is a generic version of Sanofi Aventis's Lovenox (Enoxaparin Sodium Injection) in seven dosage strengths in the US, the statement said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2021 Category: Pharmaceuticals Source Type: news

ICU Medical, Inc. Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP and 0.9% Sodium Chloride Injection, USP Due to Presence of Particulate Matter
ICU Medical, Inc. (Nasdaq: ICUI) is voluntarily recalling one single lot of Lactated Ringer's Injection, USP, and one single lot of 0.9% Sodium Chloride Injection, USP. The products are being recalled to the hospital level due to the presence of particulate matter. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 19, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Janssen Presents Phase 1 Results for RYBREVANTTM (amivantamab-vmjw) in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
August 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced preliminary data from the Phase 1 CHRYSALIS study evaluating RYBREVANTTM (amivantamab-vmjw) for the treatment of patients with non-small cell lung cancer (NSCLC) with mesenchymal-epithelial transition (MET) exon 14 skipping (METex14) mutations. The initial data showed anti-tumor activity in patients with METex14 mutations and a safety profile consistent with reported experience at the approved CHRYSALIS Phase 2 dose (RYBREVANTTM 1050 mg [
Source: Johnson and Johnson - August 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Xywav (calcium, magnesium, potassium, sodium oxybates)
Title: Xywav (calcium, magnesium, potassium, sodium oxybates)Category: MedicationsCreated: 8/18/2021 12:00:00 AMLast Editorial Review: 8/18/2021 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - August 18, 2021 Category: Sleep Medicine Source Type: news

MoviPrep (PEG-3350, Sodium Sulfate, SodiumChloride, Potassium Chloride, Sodium Ascorbate)
Title: MoviPrep (PEG-3350, Sodium Sulfate, SodiumChloride, Potassium Chloride, Sodium Ascorbate)Category: MedicationsCreated: 8/18/2021 12:00:00 AMLast Editorial Review: 8/18/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 18, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves First Drug for Idiopathic Hypersomnia FDA Approves First Drug for Idiopathic Hypersomnia
Xywav, an oral solution of calcium, magnesium, potassium, and sodium oxybates, was approved last year for treating cataplexy or excessive daytime sleepiness in patients with narcolepsy.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 13, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news